
Sezen Karakus, MD, highlights options including compounded cyclosporine, autologous serum drops, recombinant human nerve growth factor, and newer topical agents to manage refractory or neurotrophic dry eye.
Sezen Karakus, MD, is assistant professor of ophthalmology, Wilmer Eye Institute, and associate director, The Jerome L. Greene Sjögren’s Disease Center at Johns Hopkins University in Baltimore, Maryland.

Sezen Karakus, MD, highlights options including compounded cyclosporine, autologous serum drops, recombinant human nerve growth factor, and newer topical agents to manage refractory or neurotrophic dry eye.